VEGFA and cancer: To explore potential therapies for neuropathic spontaneous pain based on our findings, we tested the analgesic effects of bevacizumab, an FDA-approved anti-VEGF monoclonal antibody used in cancer treatment, which blocks angiogenesis29,30.